T46.0X2D Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, subsequent encounter

Name of the Condition

• Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, subsequent encounter

Summary

This code describes intentional self-harm involving cardiac-stimulant glycosides or similar drugs, with a subsequent medical encounter. Cardiac-stimulant glycosides (e.g., digoxin) are used to treat heart conditions like atrial fibrillation or heart failure. Intentional self-harm indicates deliberate ingestion or exposure, and a subsequent encounter means the patient is receiving care after the initial treatment phase. Clinical presentation varies based on dose and individual factors, with symptoms ranging from mild to severe.

Causes

Intentional self-harm poisoning occurs when a person deliberately takes an excessive amount of cardiac-stimulant glycosides or related drugs. This may involve ingesting more than the prescribed dose, using these substances to cause harm, or combining them with other substances. The intent to self-harm distinguishes this scenario from accidental or therapeutic-related cases.

Risk Factors

• History of mental health conditions (e.g., depression, anxiety) or suicidal ideation.
• Access to cardiac-stimulant glycosides (e.g., prescribed medications or household supplies).
• Prior episodes of self-harm or overdose.
• Social or environmental stressors contributing to intentional harm.

Symptoms

• Nausea, vomiting, or abdominal pain.
• Irregular heart rhythms (arrhythmias), including bradycardia or tachycardia.
• Dizziness, fainting, or syncope.
• Visual disturbances (e.g., blurred vision, yellow-green halos around lights).
• Weakness, fatigue, or confusion.
• Seizures or cardiac arrest in severe cases.

Diagnosis

Diagnosis requires a patient history to confirm intentional self-harm and exposure to cardiac-stimulant glycosides. Clinical evaluation includes assessing symptoms, vital signs, and cardiac monitoring (e.g., ECG) for arrhythmias. Laboratory tests may measure drug levels, electrolytes, and renal function to guide treatment. Documentation of intent and subsequent encounter status is critical for coding.

Treatment Options

Treatment focuses on stabilizing the patient, reversing toxicity, and addressing underlying intent. Interventions may include activated charcoal (if recent ingestion), antidotes (e.g., digoxin-specific Fab fragments), electrolyte correction, and cardiac monitoring. Psychiatric evaluation and support are essential to address self-harm behavior. Long-term care may involve medication management and mental health resources.

Prognosis and Follow-Up

Prognosis depends on the dose ingested, time to treatment, and patient factors (e.g., renal function). Early intervention improves outcomes, but severe toxicity can lead to complications like heart failure or death. Follow-up includes monitoring for recurrent symptoms, psychiatric care, and medication reconciliation to prevent future incidents.

Complications

• Persistent arrhythmias or cardiac dysfunction.
• Kidney injury from drug toxicity.
• Neurological effects (e.g., seizures, confusion).
• Psychological sequelae related to self-harm.
• Death in severe or untreated cases.

Lifestyle & Prevention

• Secure storage of cardiac-stimulant glycosides to limit access.
• Education on proper dosing and recognizing toxicity symptoms.
• Mental health support for individuals at risk of self-harm.
• Regular medication reviews to avoid interactions or misuse.

When to Seek Professional Help

Seek immediate medical attention if self-harm with cardiac-stimulant glycosides is suspected, or if symptoms like severe nausea, irregular heartbeat, or fainting occur. Prompt care is critical to reduce complications and address underlying intent.

Tips for Medical Coders

Document the intent (intentional self-harm) and encounter type (subsequent) clearly. Include details on exposure, clinical findings, and treatment to support code assignment. Ensure the record reflects the patient’s history and current status to justify the subsequent encounter designation.